2. Search Result
Search Result
Results for "

Ginsenoside Rh-2

" in MedChemExpress (MCE) Product Catalog:

7

Inhibitors & Agonists

6

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N0605
    Ginsenoside Rh2
    4 Publications Verification

    20(S)-Ginsenoside Rh2; 20(S)-Rh2; Ginsenoside-Rh2

    		 Caspase Apoptosis Endogenous Metabolite Cancer
    Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.
    Ginsenoside Rh2
  • HY-N1401
    20(R)-Ginsenoside Rh2
    1 Publications Verification

    		 MMP Apoptosis HSV Infection Inflammation/Immunology Cancer
    20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity . 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68 .
    20(R)-Ginsenoside Rh2
  • HY-N0605R
    Ginsenoside Rh2 (Standard)

    20(S)-Ginsenoside Rh2(Standard); 20(S)-Rh2(Standard); Ginsenoside-Rh2 (Standard)

    		 Caspase Apoptosis Endogenous Metabolite Cancer
    Ginsenoside Rh2 (Standard) is the analytical standard of Ginsenoside Rh2. This product is intended for research and analytical applications. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.
    Ginsenoside Rh2 (Standard)
  • HY-N1401R
    20(R)-Ginsenoside Rh2 (Standard)

    		MMP Apoptosis HSV Infection Inflammation/Immunology Cancer
    20(R)-Ginsenoside Rh2 (Standard) is the analytical standard of 20(R)-Ginsenoside Rh2. This product is intended for research and analytical applications. 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity . 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68 .
    20(R)-Ginsenoside Rh2 (Standard)
  • HY-125825
    Pseudoginsenoside Rh2

    		Drug Derivative Cancer
    Pseudoginsenoside Rh2, synthesized from Ginsenoside Rh2, possesses anti-cancer activitied .
    Pseudoginsenoside Rh2
  • HY-125825A
    (Z)-Pseudoginsenoside Rh2

    		Drug Isomer Cancer
    (Z)-Pseudoginsenoside Rh2 is the (Z) isoform of Pseudoginsenoside Rh2 (HY-125825), which is synthesized from Ginsenoside Rh2, possesses anti-cancer activitied .
    (Z)-Pseudoginsenoside Rh2
  • HY-N4075R
    O-Desmethylangolensin (Standard)

    		Endogenous Metabolite Metabolic Disease Cancer
    20(R)-Ginsenoside Rh2 (Standard) is the analytical standard of 20(R)-Ginsenoside Rh2. This product is intended for research and analytical applications. 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity . 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68 .
    O-Desmethylangolensin (Standard)